Multifunctional terpolymeric MRI contrast agent with superior signal enhancement in blood and tumor

Journal of Controlled Release

Volumn 167, Issue 1, 2013, Pages 11-20

  Shalviri, Alireza ^a   Foltz, Warren D ^b   Cai, Ping ^a   Rauth, Andrew M ^b   Wu, Xiao Yu ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Gadolinium and doxorubicin co loading; Magnetic resonance imaging; Polymeric MRI contrast agent; Tumor imaging; Vascular contrast

Indexed keywords

CONTRAST TO NOISE RATIO; DOXORUBICIN; GRAFT POLYMERIZATION; INTRAVENOUS ADMINISTRATION; MRI CONTRAST AGENTS; PHARMACOKINETIC PROPERTIES; TUMOR IMAGING; VASCULAR CONTRAST;

BLOOD; DRUG DELIVERY; EMULSIONS; GADOLINIUM; LOADING; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; TUMORS;

POLYMERS;

DOXORUBICIN; GADOLINIUM; METHACRYLIC ACID; PENTETIC ACID; POLYSORBATE 80;

ANIMAL CELL; ARTICLE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERIZATION; PRIORITY JOURNAL; THERMODYNAMICS;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; CONTRAST MEDIA; DOXORUBICIN; FEMALE; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; NANOPARTICLES; POLYMERS; RATS; TISSUE DISTRIBUTION;

EID: 84873475458     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.01.014     Document Type: Article

References (44)

1. P.C. Lauterbur Image formation by induced local interactions: examples employing nuclear magnetic resonance Nature 242 1973 190 191
2. G.P. Yan, L. Robinson, and P. Hogg Magnetic resonance imaging contrast agents: overview and perspectives Radiography 13 2007 e5 e19
3. R.B. Lauffer Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design Chem. Rev. 87 1987 901 927
4. S. Aime, M. Fasano, and E. Terreno Lanthanide (III) chelates for NMR biomedical applications Chem. Soc. Rev. 27 1998 19 29
5. P. Caravan, J.J. Ellison, T.J. McMurry, and R.B. Lauffer Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications Chem. Rev. 99 1999 2293 2352
6. H.J. Weinmann, R.C. Brasch, W.R. Press, and G.E. Wesbey Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent Am. J. Roentgenol. 142 1984 619 624
7. A.J. Spencer, S.A. Wilson, J. Batchelor, A. Reid, J. Pees, and E. Harpur Gadolinium chloride toxicity in the rat Toxicol. Pathol. 25 1997 245 255
8. J. Graca, F. Davison, and J. Feavel Comparative toxicity of stable rare earth compounds. III. Acute toxicity of intravenous injections of chlorides and chelates in dogs AMA Arch. Ind. Health 8 1964 555 564
9. A. Bumb, M.W. Brechbiel, and P. Choyke Macromolecular and dendrimer-based magnetic resonance contrast agents Acta Radiol. 51 2010 751 767
10. C.F.G.C. Geraldes, and S. Laurent Classification and basic properties of contrast agents for magnetic resonance imaging Contrast Media Mol. Imaging 4 2009 1 23
11. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 41 2001 189 207
12. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
13. C. Sun, C. Fang, Z. Stephen, O. Veiseh, S. Hansen, D. Lee, R.G. Ellenbogen, J. Olson, and M. Zhang Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles Nanomedicine (London, U. K.) 3 2008 495 505
14. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 5 2005 161 171
15. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Nanotheranostics and image-guided drug delivery: current concepts and future directions Mol. Pharm. 7 2010 1899 1912
16. K.Y. Choi, G. Liu, S. Lee, and X. Chen Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives Nanoscale 4 2012 330 342
17. A. Shalviri, H.K. Chan, G. Raval, M.J. Abdekhodaie, Q. Liu, H. Heerklotz, and X.Y. Wu Design of pH-responsive nanoparticles of terpolymer of poly (methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin Colloids Surf. B: Biointerfaces 101 2013 405 413
18. A. Shalviri, G. Raval, P. Prasad, C. Chan, Q. Liu, H. Heerklotz, A.M. Rauth, and X.Y. Wu pH Dependent Doxorubicin Release from Terpolymer of Starch, Polymethacrylic Acid and Polysorbate 80 Nanoparticles for Overcoming Multi-drug Resistance in Human Breast Cancer Cells Eur. J. Pharm. Biopharm. 82 2012 587 597
19. J. Treib, J.F. Baron, M. Grauer, and R. Strauss An international view of hydroxyethyl starches Intensive Care Med. 25 1999 258 268
20. M. Behne, H. Thomas, D.H. Bremerich, V. Lischke, F. Asskali, and H. Förster The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery Anesth. Analg. 86 1998 856 860
21. T. Peters The Plasma Proteins 1975 Academic Press New York
22. A. Shalviri, P. Cai, A.M. Rauth, J.T. Henderson, and X.Y. Wu Evaluation of new bi-functional terpolymeric nanoparticles for simultaneous in vivo optical imaging and chemotherapy of breast cancer Drug Delivery Transl. Res. 2 2012 437 453
23. A.J. Shuhendler, R. Staruch, W. Oakden, C.R. Gordijo, A.M. Rauth, G.J. Stanisz, R. Chopra, and X.Y. Wu Thermally-triggered 'off-on-off'response of gadolinium-hydrogel-lipid hybrid nanoparticles defines a customizable temperature window for non-invasive magnetic resonance imaging thermometry J. Control. Release 157 2011 478 484
24. E.R. Andersen, L.T. Holmaas, V. Olaisen, Process for the production of DTPA-bis anhydride, in, EP Patent 1,711,479, 2008.
25. A. Barge, G. Cravotto, E. Gianolio, and F. Fedeli How to determine free Gd and free ligand in solution of Gd chelates. A technical note Contrast Media Mol. Imaging 1 2006 184 188
26. Zetasizer Nano User Manual 2008 Malvern instruments Ltd. Worcestershire UK
27. 3 + binding to model DTPA-conjugates and DTPA-proteins: implications for their use as magnetic resonance contrast agents Magn. Reson. Med. 8 1988 180 190
28. A.E. Martell, and R.J. Motekaitis Determination and Use of Stability Constants 1992 John Wiley & Sons New York
29. P. Moldéus, J. Högberg, and S. Orrenius Isolation and use of liver cells Methods Enzymol. 52 1978 60 71
30. R. Buffa, J. Beták, S. Kettou, M. Hermannová, L. Pospísilová, and V. Velebny A novel DTPA cross-linking of hyaluronic acid and metal complexation thereof Carbohydr. Res. 346 2011 1909 1915
31. G. Sun, J. Feng, F. Jing, F. Pei, and M. Liu Synthesis and evaluation of novel polysaccharide-Gd-DTPA compounds as contrast agent for MRI J. Magn. Magn. Mater. 265 2003 123 129
32. S. Gouin, and F.M. Winnik Quantitative assays of the amount of diethylenetriaminepentaacetic acid conjugated to water-soluble polymers using isothermal titration calorimetry and colorimetry Bioconjug. Chem. 12 2001 372 377
33. H. Schmitt-Willich Stability of linear and macrocyclic gadolinium based contrast agents Br. J. Radiol. 80 2007 581 582
34. T. Haley, K. Raymond, N. Komesu, and H. Upham Toxicological and pharmacological effects of gadolinium and samarium chlorides Br. J. Pharmacol. Chemother. 17 1961 526 532
35. P.J. O'Brien, K. Chan, and P.M. Silber Human and animal hepatocytes in vitro with extrapolation in vivo Chem. Biol. Interact. 150 2004 97 114
36. 1 agent is substantially reduced when targeted to a protein microdomain Magn. Reson. Imaging 26 2008 608 617
37. J.A. Duimstra, F.J. Femia, and T.J. Meade A gadolinium chelate for detection of β-Glucuronidase: a self-immolative approach J. Am. Chem. Soc. 127 2005 12847 12855
38. R.C. Brasch Rationale and applications for macromolecular Gd-based contrast agents Magn. Reson. Med. 22 1991 282 287
39. Z.R. Lu, A.M. Mohs, Y. Zong, and Y. Feng Polydisulfide Gd (III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents Int. J. Nanomedicine 1 2006 31 40
40. 1 MR images ACS Nano 3 2009 3663 3669
41. T.H. Helbich, A. Gossman, P.A. Mareski, B. Radüchel, T.P.L. Roberts, D.M. Shames, M. Mühler, K. Turetschek, and R.C. Brasch A new polysaccharide macromolecular contrast agent for MR imaging: biodistribution and imaging characteristics J. Magn. Reson. Imaging 11 2000 694 701
42. P. Marzola, P. Farace, L. Calderan, C. Crescimanno, E. Lunati, E. Nicolato, D. Benati, A. Degrassi, A. Terron, and J. Klapwijk In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure Int. J. Cancer 104 2003 462 468
43. Y. Zong, X. Wang, K.C. Goodrich, A.M. Mohs, D.L. Parker, and Z.-R. Lu Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice Magn. Reson. Med. 53 2005 835 842
44. T.P. Padera, B.R. Stoll, J.B. Tooredman, D. Capen, E. Di Tomaso, and R.K. Jain Pathology: cancer cells compress intratumour vessels Nature 427 2004 695